intelligencia.ai
What is intelligencia.ai?
De-risk Drug Development AI is an advanced tool leveraging the power of AI to increase the probability of success in drug development. It offers solutions to uncover actionable insights in clinical development by measuring the likelihood of success across therapeutic areas and providing AI-driven risk assessments.
The tool helps in identifying underlying drivers contributing to technical and regulatory risks, optimizing clinical trial design, and standardizing risk evaluation processes. With transparent and explainable AI features, it empowers users to make confident decisions based on quality, harmonized data and eliminate the mysterious AI black box.
Pricing:
Categories:
KEY FEATURES
- ✔️ Measuring the likelihood of success in drug development.
- ✔️ Identifying underlying drivers contributing to technical and regulatory risks.
- ✔️ Optimizing clinical trial design.
- ✔️ Standardizing risk evaluation processes.
- ✔️ Transparent and explainable AI features.
USE CASES
- Assess the likelihood of success for a new drug in a specific therapeutic area by leveraging De-risk Drug Development AI's advanced analytics and risk assessment capabilities, enabling pharmaceutical companies to make informed decisions and prioritize resources effectively.
- Optimize clinical trial design using De-risk Drug Development AI to identify underlying drivers of technical and regulatory risks, thereby streamlining the development process, reducing costs, and accelerating time-to-market for new drugs.
- Collaborate with cross-functional teams within pharmaceutical organizations in real-time using De-risk Drug Development AI to standardize risk evaluation processes, enhance decision-making, and ensure alignment on strategic initiatives for successful drug development.
No reviews yet
Recommend
